基于 CiteSpace 的原发性乳腺淋巴瘤的研究进展及可视化分析吴梅于鸿

往期阅览 · All Issues-> 2025年 · 2025

临床用药研究，2025年，第1卷，第2期，第45-51页，pISSN 3105-6741、eISSN 3105-675X

发布者：Quest Press

发布日期：2026/1/11

doi 10.12479/questpress-lcyyyj.20250210

Open Access

浏览291次

Download PDF | 全文下载

基于 CiteSpace 的原发性乳腺淋巴瘤的研究进展及可视化分析

吴梅,于鸿

南京医科大学附属泰州人民医院病理科，江苏泰州，225300

摘要：目的：通过对原发性乳腺淋巴瘤（PBL）的文献进行可视化分析，展示其研究现状、研究热点及发展趋势，为PBL的研究提供指导与参考。方法：检索WebofScience（WOS）核心数据库2001—2021年发表的PBL的相关研究性文章，以纯文本的格式导出检索结果的全记录与引用的参考文献：，应用CiteSpace5.8.R3软件进行可视化分析。结果：最终纳入1899篇符合要求的文章，发文量虽有波动呈上升趋势，发表的期刊主要集中在医药/医疗/临床领域。文献共被引的聚类分析显示近年来PBL的热点话题主要是围绕BIA-ALCL，其有别于全身性的ALCL，具有独特的生物学行为。结论：应用CiteSpace对PBL近20年来的相关文献进行分析，展示出了目前关于该主题的发文趋势，揭示了研究的热点与方向，对PBL的深入研究具有重要参考价值。

关健词：原发性乳腺淋巴瘤；乳房植入物相关间变性大细胞淋巴瘤；文献计量学；知识图谱；CiteSpace

Progress and Visualization of Primary Breast Lymphoma Based on CiteSpace

Mei Wu,Hong Yu

Department of Pathology，The Affiliated Taizhou People's Hospital of Nanjing Medical University，Thaizhou，225300，China

Abstract：Objective：To provide guidance and reference for primary breast lymphoma research by visualizing and analyzing the literature on primary breast lymphoma and comprehensively presenting and analyzing its research status，research hotspots and development trends. Methods：The Web of Science（WOS）core database was searched for research articles related to primary breast lymphoma published from 2001-2021，and the full records of the search results with cited references were exported in plain text format，and CiteSpace 5.8.R3 software was applied to perform visual analysis. Results：A total of 1899 articles meeting the requirements were finally included，with an upward trend in the number of articles published，although fluctuating，and the journals published were mainly concentrated in the pharmaceutical/medical/ clinical fields Cluster analysis of co-citations in the literature revealed that the hot topic of PBL in recent years mainly revolves around BIA-ALCL，which is distinct from systemic ALCL with unique biological behaviours. Conclusion：The application of CiteSpace to analyze the relevant literature on primary breast lymphoma over the past 20 years demonstrates the current trend of publications on this topic，reveals the hot spots and directions of research，and has important reference value for the in-depth study of primary breast lymphoma.

Keywords : Primary breast lymphoma（PBL）；Breast implant-associated anaplastic large-cell lymphoma（BIA-ALCL）；Bibliometrics；Knowledge maps；CiteSpace

参考文献
[1] Talwalkar S S，Miranda R N，Valbuena J R，et al. Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms [J]. Am J SurgPathol，2008，32（9）: 1299-1309.
[2] Brogi E，Harris N L. Lymphomas of the breast: pathology and clinical behavior[J]. Semin Oncol，1999，26（3）: 357-364.
[3] Kricheldorff J，Fallenberg E M，Solbach C，et al. Breast implant-associated lymphoma [J].Dtsch Arztebl Int，2018，115（38）: 628-635.
[4] Li C X，Wu K N，Wu J Y. A bibliometric analysis of research on haze during 2000-2016[J]. Environ Sci Pollut Res Int，2017，24（32）: 24733-24742.
[5] Devos P，Ménard J. Trends in worldwide research in hypertension over the period 1999-2018: a bibliometric study[J]. Hypertension，2020，76（5）: 1649-1655.
[6] Lalezari S，Daar D A，Mathew P J，et al. Trends in rhinoplasty research: a 20-year bibliometric analysis [J]. Aesthetic Plast Surg，2018，42（4）: 1071-1084.
[7] Saab M，Dartus J，Erivan R，et al. Publication output of French orthopedic and trauma surgeons: Quantitative and qualitative bibliometric analysis of their scientific production in orthopedics and other medical fields[J]. Orthop Traumatol Surg Res，2019，105（8）: 1439-1446.
[8] Ponce F A，Lozano A M. Highly cited works in neurosurgery. Part II: the citation classics[J]. J Neurosurg，2010，112（2）: 233-246.
[9] Miao Y，Xu S Y，Chen L S，et al. Trends of long noncoding RNA research from 2007 to 2016: a bibliometric analysis[J]. Oncotarget，2017，8（47）: 83114-83127.
[10] Chen C M，Dubin R，Kim M C. Emerging trends and new developments in regenerative medicine: a scientometric update（2000 - 2014）[J]. Expert Opin Biol Ther，2014，14（9）: 1295-1317.
[11] Zhang J，Song L X，Xu L Y，et al. Knowledge domain and emerging trends in ferroptosis research: a bibliometric and knowledge-map analysis[J]. Front Oncol，2021，11: 686726.
[12] Ryan G，Martinelli G，Kuper-Hommel M，et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group[J]. Ann Oncol，2008，19（2）: 233-241.
[13] Swerdlow S H，Campo E，Pileri S A，et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood，2016，127（20）: 2375-2390.
[14] Wang Q，Yang K L，Zhang Z，et al. Characterization of global research trends and prospects on single-cell sequencing technology: bibliometric analysis[J]. J Med Internet Res，2021，23（8）: e25789.
[15] Wiseman C，Liao K T. Primary lymphoma of the breast[J]. Cancer，1972，29（6）: 1705-1712.
[16] Yhim H Y，Kang H J，Choi Y H，et al. Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma；Consortium for Improving Survival of Lymphoma（ CISL）study[J]. BMC Cancer，2010，10: 321.
[17] Shao Y B ， Sun X F ， He Y N ， et al. Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature [J]. Med Oncol，2015，32（2）: 448.
[18] Melo A，Silva S，Ferreira C，et al. Primary breast lymphoma: a mimic of inflammatory breast cancer[J]. Int J Surg Case Rep，2018，53: 410-413.
[19] Hosein P J，Maragulia J C，Salzberg M P，et al. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era[J]. Br J Haematol，2014，165（3）: 358-363.
[20] Jennings W C，Baker R S，Murray S S，et al. Primary breast lymphoma: the role of mastectomy and the importance of lymph node status[J]. Ann Surg，2007，245（5）: 784-789.
[21] Hu S X，Song Y Q，Sun X H，et al. Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure[J]. Cancer Sci，2018，109（12）: 3943-3952.
[22] Keech J A Jr ，Creech B J. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant [J]. Plast Reconstr Surg，1997，100（2）: 554- 555.
[23] Laurent C，Delas A，Gaulard P，et al. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes[J]. Ann Oncol，2016，27（2）: 306-314.
[24] Miranda R N，Aladily T N，Prince H M，et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients[J]. J Clin Oncol，2014，32（2）: 114-120.
[25] Leventaki V，Bhattacharyya S，Lim M S. Pathology and genetics of anaplastic large cell lymphoma[J]. Semin Diagn Pathol，2020，37（1）: 57-71.
[26] Rondón-Lagos M，Rangel N，Camargo-Villalba G，et al. Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma（BIA-ALCL）[J]. Eur J Surg Oncol，2021，47（5）: 942-951.
[27] Kim B，Roth C，Chung K C，et al. Anaplastic large cell lymphoma and breast implants: a systematic review[J]. Plast Reconstr Surg，2011，127（6）: 2141- 2150.
[28] Turner S D. The cellular origins of breast implant-associated anaplastic large cell lymphoma（BIA-ALCL）: implications for immunogenesis[J]. Aesthet Surg J，2019，39（Suppl_1）: S21-S27.
[29] Blombery P，Thompson E，Ryland G L，et al. Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma[J]. Oncotarget，2018，9（90）: 36126-36136.
[30] di Napoli A，Jain P，Duranti E，et al. Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes，TP53 and DNMT3A[J]. Br J Haematol，2018，180（5）: 741- 744.
[31] Weilemann A，Grau M，Erdmann T，et al. Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma[J]. Blood，2015，125（1）: 124-132.
[32] Clemens M W，Medeiros L J，Butler C E，et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma[J]. J Clin Oncol，2016，34（2）: 160-168.
[33] Kadin M E，Deva A，Xu H Y，et al. Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma[J]. Aesthet Surg J，2016，36（7）: 773-781.
[34] Bizjak M，Selmi C，Praprotnik S，et al. Silicone implants and lymphoma: The role of inflammation[J]. J Autoimmun，2015，65: 64-73.
[35] Mescam L，Camus V，Schiano J M，et al. EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas[J]. Blood，2020，135（22）: 2004-2009.

论文收录证明 / 文献检索报告

Document Retrieval Certificate / Proof of Publication Indexing

作者贡献声明 / 贡献确认书

Author Contribution Statement / Certificate of Authorship Contribution

同行评审报告 / 评审意见

Peer Review Report / Peer Review Comments

利益冲突

Conflict of Interest

作者声明不存在任何利益冲突。

The author declares no conflict of interest.

本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问： https://creativecommons.org/licenses/by/4.0/。

This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.